185
Views
2
CrossRef citations to date
0
Altmetric
Review

A systematic review of the development and testing of additional dimensions for the EQ-5D descriptive system

ORCID Icon &
Pages 431-443 | Received 03 May 2019, Accepted 26 Jun 2019, Published online: 15 Jul 2019

References

  • Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.
  • Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ (Clin Res Ed). 2004;329(7459):224–227.
  • Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost- effectiveness in health and medicine. JAMA. 1996;276(15):1253–1258.
  • Sakthong P. Measurement of clinical-effect: utility. J Med Assoc Thai. 2008;91(Suppl 2):S43–52.
  • Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017;15(2):127–137.
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
  • Scalone L, Ciampichini R, Fagiuoli S, et al. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res. 2013;22(7):1707–1716.
  • Finch AP, Brazier JE, Mukuria C. What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews. Eur J Health Econ. 2018;19(4):557–570.
  • Yang Y, Longworth L, Brazier J. An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment. Qual Life Res. 2013;22(10):2813–2828.
  • Mulhern B, Mukuria C, Barkham M, et al. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry. 2014;205(3):236–243.
  • Bozzani FM, Alavi Y, Jofre-Bonet M, et al. A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma. BMC Ophthalmol. 2012;12(1):43.
  • Oostenbrink R, Moll HA, Essink-Bot M-L. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison. J Clin Epidemiol. 2002;55(8):791–799.
  • Davis JC, Bryan S, McLeod R, et al. Exploration of the association between quality of life, assessed by the EQ-5D and ICECAP-O, and falls risk, cognitive function and daily function, in older adults with mobility impairments. BMC Geriatr. 2012;12(1):65.
  • National Institute for Health Excellence. Guide to the methods of technology appraisal third edition (draft for consultation). 2012 [cited 2013 Dec 25]. Available from: http://www.nice.org.uk/media/CB1/43/GuideToMethodsOfTechnologyAppraisal2012.pdf
  • Cheung YB, Thumboo J. Developing health-related quality-of-life instruments for use in Asia: the issues. Pharmacoeconomics. 2006;24(7):643–650.
  • Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417–1432.
  • Finch AP, Brazier JE, Mukuria C, et al. An exploratory study on using principal-component analysis and confirmatory factor analysis to identify bolt-on dimensions: the EQ-5D case study. Value Health. 2017;20(10):1362–1375.
  • Finch AP, Brazier JE, Mukuria C. Selecting bolt-on dimensions for the EQ-5D: examining their contribution to health-related quality of life. Value Health. 2019;22(1):50–61.
  • Kangwanrattanakul K, Gross CR, Sunantiwat M, et al. Exploration of a cultural-adaptation of the EQ-5D for Thai population: a “bolt-on” experiment. Qual Life Res. 2019;28(5):1207–1215.
  • Kangwanrattanakul K, Gross CR, Sunantiwat M, et al. Adding two culture-specific ‘bolt-on’ dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes. Expert Rev Pharmacoecon Outcomes Res. 2019;19(3):321–329.
  • Swinburn P, Lloyd A, Boye KS, et al. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. Value Health. 2013;16(8):1156–1162.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
  • C S. Questionnaire translation and psychometric properties evaluation. [ cited 2014 Mar 18]. Available from: www.onlinereview.segi.edu.my/chapters/vol2_chap5.pdf
  • Cohen P. Regression and correlation. Statistic in medicine. Boston: Little Brown and Company; 1974.
  • Surit P, Laohasiriwong W, Sanchaisuriya P, et al. Development of quality of life instrument for urban poor in the northeast of Thailand. J Med Assoc Thai. 2008;91(9):1447–1454.
  • Ozer ZC, Firat MZ, Bektas HA. Confirmatory and exploratory factor analysis of the caregiver quality of life index-cancer with Turkish samples. Qual Life Res. 2009;18(7):913–921.
  • Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res. 2008;17(6):895–913.
  • Kim SH, Hwang JS, Kim TW, et al. Validity and reliability of the EQ-5D for cancer patients in Korea. Support Care Cancer. 2012;20(12):3155–3160.
  • Kim TH, Jo MW, Lee SI, et al. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013;22(8):2245–2253.
  • Hunger M, Sabariego C, Stollenwerk B, et al. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2012;21(7):1205–1216.
  • NIH Natioonal Heart Lung and Blood Institute. Study quality assessment tools. 2017 [cited 2017 Mar 20]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  • Buchholz I, Janssen MF, Kohlmann T, et al. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645–661.
  • Perneger TV, Courvoisier DS. Exploration of health dimensions to be included in multi-attribute health-utility assessment. Int J Qual Health Care. 2011;23(1):52–59.
  • Yang Y, Brazier J, Tsuchiya A. Effect of adding a sleep dimension to the EQ-5D descriptive system: a “bolt-on” experiment. Med Decis Making. 2014;34(1):42–53.
  • Yang Y, Rowen D, Brazier J, et al. An exploratory study to test the impact on three “bolt-on” items to the EQ-5D. Value Health. 2015;18(1):52–60.
  • Jelsma J, Maart S. Should additional domains be added to the EQ-5D health-related quality of life instrument for community-based studies? An analytical descriptive study. Popul Health Metr. 2015;13:13.
  • Kim SH, Jo MW, Ock M, et al. Exploratory study of dimensions of health-related quality of life in the general population of South Korea. J Prev Med Public Health. 2017;50(6):361–368.
  • Hoeymans N, van Lindert H, Westert GP. The health status of the Dutch population as assessed by the EQ-6D. Qual Life Res. 2005;14(3):655–663.
  • Wolfs CA, Dirksen CD, Kessels A, et al. Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments. Health Qual Life Outcomes. 2007;5:33.
  • Luo N, Wang X, Ang M, et al. A vision “bolt-on” item could increase the discriminatory power of the EQ-5D index score. Value Health. 2015;18(8):1037–1042.
  • Krabbe PF, Stouthard ME, Essink-Bot ML, et al. The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol. 1999;52(4):293–301.
  • Longworth L, Yang Y, Young T, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1–224.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.